Site Home Link
(603) 298-5509
Member Log In Members Login
360
Publications
750
Participating Centers
780,273
Procedures Captured
  • About
    • About
    • SVS VQI Collaboration
    • The Vascular Patient
    • Importance of Quality Improvement
    • Importance of Data Accuracy
    • Importance of Long Term Follow-Up
    • Importance of Regional Meetings
    • SVS VQI Procedures Collected
    • Participating SVS VQI Centers
    • SVS Patient Safety Organization (PSO)
    • M2S Cloud Based Platform
    • Vascular Societal Endorsement of the VQI
  • Quality Improvement
    • Quality Improvement
    • QI Process
    • National QI Initiatives
    • QI Projects
    • Participation Awards
  • Regional Groups
    • Regional Groups
    • Regional Projects
    • Current Regional Quality Groups
    • Regional Quality Group Map
  • Industry Partners
    • Industry Partners
    • For Device and Drug Manufacturers
    • For Physicians and Hospitals
    • Vascular Technology Council (VTC)
    • Corporate Support
  • Data Analysis
    • Data Analysis
    • SVS VQI Publications
    • RAC Approved Project Search
    • SVS VQI Medicare Matched Blinded Datasets
    • SVS PSO Data Analysis Guidelines for Use
    • Industry Project Charters and Process
      • TCAR Surveillance Project
      • CREST-2 Randomized Control Trial
  • Members Only
    • Members Login
    • Members’ Only – National Data
    • Forums
  • Resources
    • Reporting
    • Articles
    • Past Webinars/Events
    • VQI Annual Meeting – DATE CHANGE!
    • SVS VQI Risk Calculators
    • Cardiac Risk Predictor
    • FDA Communication
  • Contact Us/Join Us
    • Directory
    • Join the SVS VQI
    • Value in Participation
    • Procedures Collected
    • Vascular Medicine Consult Registry (New)
Home / Resources / FDA Communication

News
  • FDA Update: Importance of At Least Yearly, Lifelong Follow-Up with Use of Endologix AFX Endovascular Graft Systems

    December 9, 2020 2:49 pm

  • SVS VQI Surpasses 700 Participating Centers and 700,000 Procedures

    September 22, 2020 10:52 am

  • The July VQI e-Newsletter is up – please read

    July 31, 2020 11:41 am

  • ACC, SVS Join Forces on Single Vascular Registry

    June 25, 2020 10:31 am

FDA Communication

News/Updates from the U.S. Food and Drug Administration (FDA)

Dec. 29, 2020

FDA designates recalls of two vascular catheters as Class I

Dec. 17, 2020

Penumbra’s Urgent Voluntary Recall of JET 7 Catheters with Xtra Flex Technology Due to Increased Risk of Mortality and Serious Injury – Urgent Letter to Health Care Providers

Dec. 9, 2020

FDA Update: Importance of At Least Yearly, Lifelong Follow-Up with Use of Endologix AFX Endovascular Graft Systems

Login Area

Please log into the members area.

Reset your password
Testimonials
The VQI enables every surgeon to compare his or her outcomes with those at the regional and national level in a de-identified manner for nearly every procedure a vascular surgeon performs. The VQI also offers a rich dataset of variables and outcomes relevant to vascular surgeons which are ideally suited for performing research.

Dr. Grace Wang

Hospital of the University of Pennsylvania

The SVS wishes to thank the following companies for their grant support of the VQI

Quality Champions

Quality Partners

Quality Associates

  • M2S PATHWAYS
  • Registry Updates
  • Cardiac Risk Predictors
  • VQI Annual Meeting

Vascular Quality Initiative® and VQI® are Registered Trademarks of the Society for Vascular Surgery®. Copyright © 2021. All rights reserved.

Email Us | (603) 298-5509